| Literature DB >> 34795703 |
Meseret Mitiku Gemechu1, Tesfaye Assefa Tadesse1, Getahun Negash Takele1, Fithamlak Solomon Bisetegn2, Yonas Alem Gesese3, Tizazu Zenebe Zelelie4.
Abstract
BACKGROUND: Hospital acquired infections (HAIs) are one of the global concerns in resource limited settings. The aim of the study was to determine bacteria profile and their antimicrobial susceptibility patterns among patients admitted at surgical and medical wards.Entities:
Keywords: Antimicrobial susceptibility patterns; bacterial profile; hospital acquired infections
Mesh:
Substances:
Year: 2021 PMID: 34795703 PMCID: PMC8568252 DOI: 10.4314/ahs.v21i2.5
Source DB: PubMed Journal: Afr Health Sci ISSN: 1680-6905 Impact factor: 0.927
Age and sex distribution of patients admitted in surgical and medical wards of MaddaWalabu University Goba Referral Hospital from November 2016 to July 2017
| Age | Male, No | Female No | Total |
|
| 24(11.6) | 21(10.1) | 45(21.7) |
|
| 49(23.7) | 30(14.5) | 79(38.2) |
|
| 26(12.6) | 14(6.8) | 40(19.3) |
|
| 17(8.2) | 8(3.9) | 25(12.1) |
|
| 5(2.4) | 6(2.9) | 11(5.3) |
|
| 4(1.9) | 3(1.4) | 7(3.4) |
|
| |||
|
| 125(60.4) | 82(39.6) | 207(100) |
Figure 1Distribution of Healthcare associated infections by sex among patients (n=51) admitted in surgical and medical wards of Madda-Walabu University Goba Referral Hospital
Figure 2Distribution of bacterial isolates (n=35)from surgical site infected patients admitted in surgical wards of MaddaWalabu university Goba referral hospital from November 2016 to July 2017.
Figure 3Distribution of bacterial isolates (n=27) from urinary tract infected patients admitted in medical wards of MaddaWalabu University Goba Referral Hospital from November 2016 to July 2017.
Antimicrobial Susceptibility Patterns of Gram-Positive Bacteria (n=19) isolated from patients admitted to surgical and medical wards of MaddaWalabu University Goba Referral Hospital from November 2016 to July 2017
| Isolates | Antimicrobial drugs | ||||||||||||||
| AMP | AMC | CAF | CN | CX | MET | PEN | AML | TTC | SXT | CRO | DO | NOR | CIP | ||
| S | - | 2 | 1 | - | 2 | - | - | - | 1 | - | 6 | 2 | 4 | 6 | |
| I | 1 | - | - | 2 | - | - | - | - | 1 | - | - | - | 1 | - | |
| R | 10 | 9 | 10 | 9 | 9 | 11 | 11 | 11 | 9 | 11 | 5 | 9 | 6 | 5 | |
| CoNS (n=7) | S | - | 4 | 1 | 2 | 1 | - | - | - | - | - | 4 | 3 | 4 | 3 |
| I | - | - | - | 1 | - | - | - | 1 | - | - | 2 | - | 1 | - | |
| R | 7 | 3 | 6 | 4 | 6 | 7 | 7 | 6 | 7 | 7 | 1 | 4 | 2 | 4 | |
| Enterococcus | S | - | - | - | - | - | - | - | - | 1 | - | - | 1 | 1 | 1 |
| I | - | 1 | - | - | - | - | - | - | - | - | - | - | - | - | |
| R | 1 | - | 1 | 1 | 1 | 1 | 1 | 1 | - | 1 | 1 | - | - | - | |
| Total | S | - | 31.6 % | 10.5% | 10.5% | 15.8% | - | - | - | 10.5 % | - | 52.6 % | 31.6% | 47.4 % | 52.6% |
| I | - | 5.2% | - | 15.8 | - | - | - | 5.3% | 5.3% | - | 10.5 | - | 10.5 | - | |
| R | 100 | 63.2 | 89 | 73.7 | 84.2 | 100 | 100 | 94.7 | 84.2 | 100 | 36.9 | 68.4 | 42.1 | 47.4 | |
S= Sensitive; I=Intermediate; R=Resistant
Expressed in percent
AMP: Ampicillin; AMC: Amoxicillin-Clavulanic acid; CAF: Chloramphenicol; CN: Gentamicin; CX: Cloxacillin; MET: Methicillin; P: Penicillin; AML: Amoxicillin; TTC: Tetracycline; SXT: Trimethoprim-sulphamethoxazole; CRO: Ceftriaxone; DO: Doxycycline; NOR: Norfloxacin; CIP: Ciprofloxacin
Antimicrobial Susceptibility Patterns of Gram-Negative Bacteria isolates (n=43) from patients admitted to surgical and medical wards of MaddaWalabu University Goba Referral Hospital from November 2016 to July 2017
| Isolates | Antimicrobial drugs | |||||||||||||
| AMP | AMC | CAF | CN | NA | NF | AML | TTC | SXT | CRO | DO | NOR | CIP | ||
| S | - | 3 | 4 | 7 | 5 | 10 | - | - | - | 6 | 3 | 9 | 8 | |
| I | - | 1 | 1 | 2 | 1 | - | 1 | - | - | 1 | - | - | - | |
| R | 13 | 9 | 8 | 4 | 7 | 3 | 12 | 13 | 13 | 6 | 10 | 4 | 5 | |
| S | - | 1 | 1 | 1 | 3 | 7 | - | - | - | 1 | - | 3 | 2 | |
| I | - | - | 1 | - | 1 | 1 | - | - | - | - | - | 2 | 1 | |
| R | 12 | 11 | 10 | 11 | 8 | 4 | 12 | 12 | 12 | 11 | 12 | 7 | 9 | |
| S | - | 1 | 2 | 2 | 2 | 5 | - | - | - | 6 | 1 | 5 | 4 | |
| I | - | - | - | 1 | 2 | 1 | - | - | - | 1 | 1 | 1 | - | |
| R | 10 | 9 | 8 | 7 | 6 | 4 | 10 | 10 | 10 | 3 | 8 | 4 | 6 | |
| S | - | 1 | - | 3 | 3 | 3 | - | - | - | 2 | 1 | 3 | 2 | |
| I | - | - | - | - | 1 | - | - | - | - | - | 1 | 1 | 1 | |
| R | 5 | 4 | 5 | 2 | 1 | 2 | 5 | 5 | 5 | 3 | 3 | 1 | 2 | |
| S | - | - | 1 | - | 2 | 2 | - | - | - | 1 | - | 1 | 1 | |
| I | - | - | - | 1 | - | - | - | - | - | - | - | - | - | |
| R | 2 | 2 | 1 | 1 | - | - | 2 | 2 | 2 | 1 | 2 | 1 | 1 | |
| S | - | - | - | - | - | 1 | - | - | - | - | - | 1 | - | |
| I | - | - | - | 1 | 1 | - | - | - | - | - | - | - | 1 | |
| R | 1 | 1 | 1 | - | - | - | 1 | 1 | 1 | 1 | 1 | - | - | |
| Total | S | - | 14.0% | 18. 6% | 30. 2% | 34. 9% | 65. 1% | - | - | - | 37.2% | 11. 6% | 51.2% | 39.5% |
| I | - | 2.3% | 4.7% | 11. 6% | 13. 9% | 4.7% | 2.3% | - | - | 4.7% | 4.7% | 9.3% | 6.9% | |
| R | 100% | 83.7% | 76.7% | 58.2% | 51.2% | 30.2% | 97.7% | 100% | 100% | 58.1% | 83.7% | 39.5% | 53.6% | |
S= Sensitive; I=Intermediate; R=Resistant; ** Expressed in percent
AMP: Ampicillin; AMC: Amoxicillin-Clavulanic acid; CAF: Chloramphenicol; CN: Gentamicin; NA: Nalidixic acid; NF: Nitrofurantoin; SXT: Trimethoprim-sulphamethoxazole; CRO: Ceftriaxone; DO: Doxycycline; NOR: Norfloxacin; CIP: Ciprofloxacin